DOI QR코드

DOI QR Code

In vitro assay for osteoinductive activity of different demineralized freeze-dried bone allograft

  • Vaziri, Shahram (Department of Periodontology, Dental school, Shahid Beheshti University of Medical Sciences) ;
  • Vahabi, Surena (Department of Periodontology, Dental school, Shahid Beheshti University of Medical Sciences) ;
  • Torshabi, Maryam (Department of Dental Material, Dental school, Shahid Beheshti University of Medical Sciences) ;
  • Hematzadeh, Somayeh (Department of Periodontology, Dental school, Qazvin University of Medical Sciences)
  • Received : 2012.10.23
  • Accepted : 2012.11.28
  • Published : 2012.12.31

Abstract

Purpose: Various bone graft materials have been used for periodontal tissue regeneration. Demineralized freeze-dried bone allograft (DFDBA) is a widely used bone substitute. The current widespread use of DFDBA is based on its potential osteoinductive ability. Due to the lack of verifiable data, the purpose of this study was to assess the osteoinductive activity of different DFDBAs in vitro. Methods: Sarcoma osteogenic (SaOS-2) cells (human osteoblast-like cells) were exposed to 8 mg/mL and 16 mg/mL concentrations of three commercial types of DFDBA: Osseo+, AlloOss, and Cenobone. The effect of these materials on cell proliferation was determined using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. The osteoinductive ability was evaluated using alizarin red staining, and the results were confirmed by evaluating osteogenic gene expression using reverse transcription polymerase chain reaction (RT-PCR). Results: In the SaOS-2 cells, an 8 mg/mL concentration of Osseo+ and Cenobone significantly increased cell proliferation in 48 hours after exposure (P<0.001); however, in these two bone materials, the proliferation of cells was significantly decreased after 48 hours of exposure with a 16 mg/mL concentration (P<0.001). The alizarin red staining results demonstrated that the 16 mg/mL concentration of all three tested DFDBA induced complete morphologic differentiation and mineralized nodule production of the SaOS-2 cells. The RT-PCR results revealed osteopontin gene expression at a 16 mg/mL concentration of all three test groups, but not at an 8 mg/mL concentration. Conclusions: These commercial types of DFDBA are capable of decreasing proliferation and increasing osteogenic differentiation of the SaOS-2 cell line and have osteoinductive activity in vitro.

Keywords

References

  1. Urist MR. Bone histogenesis and morphogenesis in implants of demineralized enamel and dentin. J Oral Surg 1971;29:88-102.
  2. Schwartz Z, Mellonig JT, Carnes DL Jr, de la Fontaine J, Cochran DL, Dean DD, et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 1996;67:918-26.
  3. Bormann N, Pruss A, Schmidmaier G, Wildemann B. In vitro testing of the osteoinductive potential of different bony allograft preparations. Arch Orthop Trauma Surg 2010;130:143-9.
  4. Zhang M, Powers RM Jr, Wolfinbarger L Jr. A quantitative assessment of osteoinductivity of human demineralized bone matrix. J Periodontol 1997;68:1076-84.
  5. Shigeyama Y, D'Errico JA, Stone R, Somerman MJ. Commercially-prepared allograft material has biological activity in vitro. J Periodontol 1995;66:478-87.
  6. Pinholt EM, Haanaes HR, Roervik M, Donath K, Bang G. Alveolar ridge augmentation by osteoinductive materials in goats. Scand J Dent Res 1992;100:361-5.
  7. Becker W, Lynch SE, Lekholm U, Becker BE, Caffesse R, Donath K, et al. A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like growth factor-I or demineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants. J Periodontol 1992;63: 929-40.
  8. Becker W, Schenk R, Higuchi K, Lekholm U, Becker BE. Variations in bone regeneration adjacent to implants augmented with barrier membranes alone or with demineralized freeze-dried bone or autologous grafts: a study in dogs. Int J Oral Maxillofac Implants 1995;10:143-54.
  9. Rummelhart JM, Mellonig JT, Gray JL, Towle HJ. A comparison of freeze-dried bone allograft and demineralized freeze-dried bone allograft in human periodontal osseous defects. J Periodontol 1989;60:655-63.
  10. Schwartz Z, Somers A, Mellonig JT, Carnes DL Jr, Wozney JM, Dean DD, et al. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material. J Periodontol 1998;69:1337-45.
  11. Becker W, Urist MR, Tucker LM, Becker BE, Ochsenbein C. Human demineralized freeze-dried bone: inadequate induced bone formation in athymic mice. A preliminary report. J Periodontol 1995;66:822-8.
  12. Kumaran ST, Arun KV, Sudarsan S, Talwar A, Srinivasan N. Osteoblast response to commercially available demineralized bone matrices: an in-vitro study. Indian J Dent Res 2010;21:3-9.
  13. Lian JB, Stein GS. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids). J Oral Implantol 1993;19:95-105.
  14. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, et al. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 1987;47:4961-6.
  15. Carnes DL Jr, De La Fontaine J, Cochran DL, Mellonig JT, Keogh B, Harris SE, et al. Evaluation of 2 novel approaches for assessing the ability of demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 1999;70:353-63.
  16. Rochet N, Loubat A, Laugier JP, Hofman P, Bouler JM, Daculsi G, et al. Modification of gene expression induced in human osteogenic and osteosarcoma cells by culture on a biphasic calcium phosphate bone substitute. Bone 2003;32:602-10.
  17. Trojani C, Weiss P, Michiels JF, Vinatier C, Guicheux J, Daculsi G, et al. Three-dimensional culture and differentiation of human osteogenic cells in an injectable hydroxy propylmethylcellulose hydrogel. Biomaterials 2005;26: 5509-17.
  18. Han B, Tang B, Nimni ME. Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrix. J Orthop Res 2003;21:648-54.
  19. Carinci F, Piattelli A, Degidi M, Palmieri A, Perrotti V, Scapoli L, et al. Effects of demineralized freeze-dried bone allograft on gene expression of osteoblastlike MG63 cells. Int J Periodontics Restorative Dent 2007;27:596-601.

Cited by

  1. Clinical and radiographic evaluation of demineralized bone matrix (grafton) as a bone graft material in the treatment of human periodontal intraosseous defects vol.17, pp.4, 2013, https://doi.org/10.4103/0972-124x.118323
  2. Growth factors in orthopaedic surgery: demineralized bone matrix versus recombinant bone morphogenetic proteins vol.39, pp.1, 2012, https://doi.org/10.1007/s00264-014-2562-0
  3. In vitro effect of mineralized and demineralized bone allografts on proliferation and differentiation of MG-63 osteoblast-like cells vol.17, pp.1, 2016, https://doi.org/10.1007/s10561-015-9516-7
  4. In vitro comparison of the efficacy of TGF-β1 and PDGF-BB in combination with freeze-dried bone allografts for induction of osteogenic differentiation in MG-63 osteoblast-like cells vol.27, pp.12, 2016, https://doi.org/10.1007/s10856-016-5802-6
  5. Enhanced osteogenesis on biofunctionalized poly(ɛ-caprolactone)/poly(m-anthranilic acid) nanofibers vol.31, pp.5, 2012, https://doi.org/10.1177/0885328216660379
  6. Comparative clinical and radiographic evaluation of mineralized cancellous bone allograft (puros ® ) and autogenous bone in the treatment of human periodontal intraosseous defects: 6-mo vol.6, pp.3, 2012, https://doi.org/10.4103/2231-0762.197207
  7. RGD functionalized poly(ε-caprolactone)/poly(m-anthranilic acid) electrospun nanofibers as high-performing scaffolds for bone tissue engineering RGD functionalized PCL/P3ANA nanofibers vol.66, pp.3, 2012, https://doi.org/10.1080/00914037.2016.1190929